1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
FY26 round is over: the required pre-application (LOI) gate closed 4 Sep 2026. Between funding cycles - CDMRP has run this award every year since FY11, so watch cdmrp.health.mil for the next round.
Historical funding: Up to $910,000 (Single PI) or $1,000,000 (Partnering PI Option) over 3 years
Prior eligibility: Unrestricted, open to any type of entity. Preliminary data is required. Clinical trials, including pilot clinical trials and clinical trial readiness studies, are allowed.
Duchenne Muscular Dystrophy Research Program (DMDRP) Clinical/Translational Research Award - Funding Level 1 is sponsored by Department of Defense, Defense Health Agency Contracting Activity (DHACA). This award supports translational studies beyond basic research with the potential for near-term impact in clinical research or application. It funds small-scale preclinical and/or clinical research to support clinical trial readiness.
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleThe Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read articleDoW's 2026 SBIR Broad Agency Announcement now operates on a monthly pre-release / quarterly close cadence. The 42 topics closing June 24 are the first test of whether the new rhythm produces the steady-state deal flow defense innovators have been asking for since 2022.
Read article